Ben Tre Pharmaceutical JSC (HOSE:DBT)
Vietnam
· Delayed Price · Currency is VND 10,550
+150 (1.44%)
At close: Mar 6, 2026
HOSE:DBT Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Net Income | 14,034 | 14,581 | 16,195 | 21,396 | 20,193 | Upgrade
|
| Depreciation & Amortization | 18,411 | 16,374 | 8,884 | 13,336 | 13,007 | Upgrade
|
| Other Amortization | - | 734.19 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -21,208 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -6,478 | 4,054 | - | - | Upgrade
|
| Other Operating Activities | 11,553 | -4,195 | -1,440 | -7,223 | -4,208 | Upgrade
|
| Change in Accounts Receivable | -75,203 | 37,638 | -12,200 | 11,450 | -44,032 | Upgrade
|
| Change in Inventory | 47,771 | -108,917 | 65,536 | -104,463 | 18,380 | Upgrade
|
| Change in Accounts Payable | -2,133 | 16,154 | -84,186 | -9,390 | 914.59 | Upgrade
|
| Change in Other Net Operating Assets | 5,648 | 7,313 | 3,518 | 776.47 | -15,069 | Upgrade
|
| Operating Cash Flow | -1,125 | -26,796 | 361.64 | -74,118 | -10,814 | Upgrade
|
| Capital Expenditures | -4,058 | -14,072 | -7,318 | -6,822 | -10,513 | Upgrade
|
| Sale of Property, Plant & Equipment | 16,566 | 15,338 | 2,126 | - | 7,534 | Upgrade
|
| Investment in Securities | 1,002 | -19,496 | -32,965 | -28,148 | 2,557 | Upgrade
|
| Other Investing Activities | -2,800 | 4,036 | 2,812 | 6,570 | 8,519 | Upgrade
|
| Investing Cash Flow | 5,528 | -32,541 | -62,566 | -42,400 | 8,097 | Upgrade
|
| Long-Term Debt Issued | 880,491 | 888,931 | 782,262 | 697,476 | 538,385 | Upgrade
|
| Total Debt Issued | 880,491 | 888,931 | 782,262 | 697,476 | 538,385 | Upgrade
|
| Long-Term Debt Repaid | -871,901 | -861,447 | -719,327 | -592,327 | -537,279 | Upgrade
|
| Total Debt Repaid | -871,901 | -861,447 | -719,327 | -592,327 | -537,279 | Upgrade
|
| Net Debt Issued (Repaid) | 8,590 | 27,484 | 62,935 | 105,148 | 1,106 | Upgrade
|
| Issuance of Common Stock | - | 19,062 | 7,000 | 12,143 | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | -97.85 | - | Upgrade
|
| Common Dividends Paid | - | - | - | -13,529 | -18,343 | Upgrade
|
| Financing Cash Flow | 8,590 | 46,546 | 69,935 | 103,665 | -17,237 | Upgrade
|
| Foreign Exchange Rate Adjustments | -4.39 | 6.49 | 23.19 | - | - | Upgrade
|
| Net Cash Flow | 12,988 | -12,785 | 7,754 | -12,853 | -19,954 | Upgrade
|
| Free Cash Flow | -5,184 | -40,869 | -6,956 | -80,940 | -21,328 | Upgrade
|
| Free Cash Flow Margin | -0.60% | -4.71% | -0.86% | -10.11% | -2.63% | Upgrade
|
| Free Cash Flow Per Share | -235.98 | -2187.12 | -409.38 | - | - | Upgrade
|
| Cash Interest Paid | 32,691 | 40,463 | 39,419 | 15,165 | 14,031 | Upgrade
|
| Cash Income Tax Paid | 10,262 | 10,687 | 1,915 | 3,736 | 3,117 | Upgrade
|
| Levered Free Cash Flow | 1,076 | -28,869 | - | -87,108 | 3,759 | Upgrade
|
| Unlevered Free Cash Flow | 26,489 | -3,799 | - | -77,618 | 12,015 | Upgrade
|
| Change in Working Capital | -23,916 | -47,813 | -27,332 | -101,627 | -39,806 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.